Safety, Pharmacokinetics, Immunogenicity BCD-256-1 and Divozilimab in Subjects With Systemic Lupus Erythematosus

Clinical trial NCT07136389 · RECRUITING

Trial details

NCT number: NCT07136389
Sponsor: Biocad
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erthematosus

Start date: 2025-03-27
Primary completion: 2026-01-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.